Armata Pharmaceuticals, Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Los Angeles, CA
ARMP chart
What traders are saying about $ARMP
Latest postsArmata Pharmaceuticals, Inc. news
- Armata Pharmaceuticals, Inc. News — DUS:TG1N
TradingView ·
- Armata Pharmaceuticals, Inc. (ARMP) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Armata Pharmaceuticals Inc (TG1N.MU) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- ARMP: AP-SA02 advanced to Phase 3 with FDA designations; net loss surged on non-cash charge
TradingView ·
- Krystal Biotech, Inc. (KRYS) Surpasses Q3 Earnings and Revenue Estimates
Yahoo Finance ·
- Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances in the United States
Yahoo Finance ·
- Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
Yahoo Finance ·
- Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates
Yahoo Finance ·
- Armata Pharmaceuticals Shares Rise 8% After FDA Grants AP-SA02 Breakthrough Therapy Designation
investorshub.advfn.com ·
- Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
Yahoo Finance ·
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
Armata Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$173.8M | -$18.9M | -$69.0M | -$36.9M |
| Diluted EPS | $-4.80 | $-0.89 | $-1.91 | $-1.08 |
| Total assets (year end) | $76.9M | $86.4M | $98.4M | $95.8M |
| Cash and equivalents (year end) | $8.7M | $9.3M | $13.5M | $14.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Armata Pharmaceuticals, Inc.
- Ticker
- ARMP (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Los Angeles, CA
- Incorporated in
- WA
- Fiscal year end
- December 31
- SEC CIK
- 921114
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
Frequently asked questions
What exchange is Armata Pharmaceuticals, Inc. listed on?
Armata Pharmaceuticals, Inc. trades on the NYSE under the ticker symbol ARMP.
What industry is Armata Pharmaceuticals, Inc. in?
Armata Pharmaceuticals, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Armata Pharmaceuticals, Inc. headquartered?
Armata Pharmaceuticals, Inc.'s business address on file with the SEC is in Los Angeles, CA.
When does Armata Pharmaceuticals, Inc.'s fiscal year end?
Armata Pharmaceuticals, Inc.'s fiscal year ends on December 31.